SOX17 and pulmonary arterial hypertension: Interestingly, a genome-wide association study of common SNPs involving both the PAH Biobank and the UK cohort identified SNPs in a putative endothelial-acting enhancer region of SOX17 in PAH [51], suggesting that common variants may play an important role in susceptibility to PAH.